Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monte Rosa Therapeutics (GLUE) Prepaid Assets (2023 - 2025)

Monte Rosa Therapeutics (GLUE) has 3 years of Prepaid Assets data on record, last reported at $5.6 million in Q3 2025.

  • For Q3 2025, Prepaid Assets fell 33.61% year-over-year to $5.6 million; the TTM value through Sep 2025 reached $5.6 million, down 33.61%, while the annual FY2024 figure was $5.1 million, 55.37% up from the prior year.
  • Prepaid Assets reached $5.6 million in Q3 2025 per GLUE's latest filing, down from $6.5 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $8.4 million in Q3 2024 and bottomed at $3.3 million in Q4 2023.
  • Average Prepaid Assets over 3 years is $5.3 million, with a median of $5.5 million recorded in 2024.
  • Peak YoY movement for Prepaid Assets: soared 103.53% in 2024, then tumbled 33.61% in 2025.
  • A 3-year view of Prepaid Assets shows it stood at $3.3 million in 2023, then skyrocketed by 55.37% to $5.1 million in 2024, then rose by 9.3% to $5.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $5.6 million in Q3 2025, $6.5 million in Q2 2025, and $4.8 million in Q1 2025.